CARMA FUND

CARMA FUND is a German early-stage investment fund founded in 2022 that backs European life science and healthcare innovations. Its vehicle, CARMA FUND I, is structured as a combined venture capital and transfer fund - a format designed to move technologies out of academic research and toward practical application and patient access. The fund reports €56 million under management across 19 portfolio companies.

Investment activity spans therapeutics, medtech and digital health, with particular attention to oncology, immunology, neurology, respiratory medicine, medical devices and health-data platforms. The fund describes its approach as longer-horizon and flexible in structure, paired with a risk-conscious stance on value creation - a fit with the extended development timelines typical of life science assets. It invests at early stage in both businesses and projects, and is open to opportunities from across Europe.

Working method leans on collaboration with technology-transfer offices and industry partners, combining academic access with cross-sector expertise and a European syndication network. The stated mission is to help promising science reach patients through product development and market entry. Team members are based across Germany, in Munich, Frankfurt am Main, Hamburg and Leipzig.